# Study of the Safety and Effectiveness of NXN-188 for the Treatment of Migraine Headache Without Aura

> **NCT00959751** · PHASE2 · COMPLETED · sponsor: **NeurAxon Inc.** · enrollment: 195 (actual)

## Conditions studied

- Migraine Without Aura

## Interventions

- **DRUG:** NXN-188
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00959751
- **Lead sponsor:** NeurAxon Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-02
- **Final completion:** 2010-03
- **Target enrollment:** 195 (ACTUAL)
- **Last updated:** 2014-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00959751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00959751, "Study of the Safety and Effectiveness of NXN-188 for the Treatment of Migraine Headache Without Aura". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00959751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*